Authors
Serena Fondelli, Guglielmo Arzilli, Filipa Alves da Costa, Christian Brixko, Maria Butí, Joaquin Cabezas, Nicola Cocco, Olivia Dawson, Charlotte Deogan, Gabriele Fischer, Arkadiusz Komorowski, Fadi Meroueh, Linda Montanari, Sara Mazzilli, Éamonn O'Moore, Roberto Ranieri, Rafaela Rigoni, Alessio Saponaro, Carole Seguin-Devaux, Ehab Salah, Thomas Seyler, Heino Stöver, Lara Tavoschi, Erika Duffell
Published in
Liver international : official journal of the International Association for the Study of the Liver. Volume 46. Issue 10. Pages e70874.
Abstract
People living in prison are disproportionately affected by hepatitis B and C, yet access to prevention, testing, and treatment services remains inconsistent across Europe. Addressing this gap is critical to achieving viral hepatitis elimination targets by 2030. EuroHePP is a European toolkit developed to support national responses to viral hepatitis in prison settings. It was created through a structured, multi-stage process involving evidence review, stakeholder consultations, and expert validation. The toolkit provides practical guidance across the full continuum of care, including prevention, testing, treatment, and monitoring, and promotes micro-elimination approaches tailored to prison populations. It emphasises evidence-based interventions such as opt-out testing, decentralised and simplified models of care, harm reduction strategies, and continuity of care after release. By offering adaptable tools and frameworks for policymakers and practitioners, EuroHePP aims to strengthen prison health systems, reduce health inequalities, and accelerate progress towards hepatitis elimination at national and regional levels.
PMID:
42741862
Bibliographic data and abstract were imported from PubMed on 15 Sep 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 11
- Comments 0